Mifepristone has met FDA safety and efficacy standard
has met the safety and efficacy standard according to the FDA review
Senate committee hearing
H
Heidi OvertonFood and Drug Administration · pick to lead the Food and Drug Administration
has met the safety and efficacy standard according to the FDA review
Senate committee hearing
“President Trump’s direction for me in this role, should I be confirmed, is to ‘go fast.’” Overton says in the statement. “Slow and prohibitive requirements for cutting edge therapies at…”
“Novartis now expects to speak with the FDA about a potential accelerated approval of pelabresib before the end of the year, CEO Vas Narasimhan told investors on a call Tuesday.”
“The industry has gotten more consolidated. Prices are higher than ever. Access is worse than ever.”
“The rising costs are unsustainable for individuals, for businesses, and for the country. What kind of intervention is a different question.”